[go: up one dir, main page]

TW201613631A - Ghrelin secretion promoter - Google Patents

Ghrelin secretion promoter

Info

Publication number
TW201613631A
TW201613631A TW104120557A TW104120557A TW201613631A TW 201613631 A TW201613631 A TW 201613631A TW 104120557 A TW104120557 A TW 104120557A TW 104120557 A TW104120557 A TW 104120557A TW 201613631 A TW201613631 A TW 201613631A
Authority
TW
Taiwan
Prior art keywords
secretion promoter
ghrelin secretion
ghrelin
promoter
saccharide
Prior art date
Application number
TW104120557A
Other languages
Chinese (zh)
Other versions
TWI726846B (en
Inventor
Kentaro Nakamura
Taketo Yamaji
Akina SASAYAMA
Hidekazu Tonouchi
Original Assignee
Meiji Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Co Ltd filed Critical Meiji Co Ltd
Publication of TW201613631A publication Critical patent/TW201613631A/en
Application granted granted Critical
Publication of TWI726846B publication Critical patent/TWI726846B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention pertains to a new ghrelin secretion promoter and, more specifically, to a ghrelin secretion promoter comprising: a protein hydrolyzate and a fermented milk protein, as proteins; a medium-chain fatty acid, as a lipid; and a saccharide.
TW104120557A 2014-06-25 2015-06-25 Ghrelin secretion enhancer TWI726846B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014-130143 2014-06-25
JP2014130143 2014-06-25

Publications (2)

Publication Number Publication Date
TW201613631A true TW201613631A (en) 2016-04-16
TWI726846B TWI726846B (en) 2021-05-11

Family

ID=54938269

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104120557A TWI726846B (en) 2014-06-25 2015-06-25 Ghrelin secretion enhancer

Country Status (5)

Country Link
JP (1) JP6657084B2 (en)
CN (1) CN106535915B (en)
SG (1) SG11201610051YA (en)
TW (1) TWI726846B (en)
WO (1) WO2015199192A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI754662B (en) * 2016-08-19 2022-02-11 日商明治股份有限公司 Composition for improving peripheral nerve damage caused by anticancer agent

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6813974B2 (en) * 2016-07-14 2021-01-13 株式会社明治 Ghrelin secretagogue
JP6970498B2 (en) * 2016-11-29 2021-11-24 花王株式会社 milk beverage
JP6515244B2 (en) * 2018-11-14 2019-05-15 株式会社明治 Ghrelin secretagogue
JP2020083852A (en) * 2018-11-30 2020-06-04 株式会社明治 Stress disease preventive composition
JPWO2022191184A1 (en) * 2021-03-08 2022-09-15
WO2024128185A1 (en) * 2022-12-12 2024-06-20 株式会社明治 Composition for promoting ghrelin secretion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2133090A4 (en) * 2007-03-12 2012-02-01 Megmilk Snow Brand Co Ltd Growth hormone secretion stimulator
TWI612902B (en) * 2009-11-30 2018-02-01 Meiji Co Ltd Use of a composition for manufacturing an improved intestinal functional composition and preparation method thereof
JP2013227309A (en) * 2012-03-30 2013-11-07 Ajinomoto Co Inc Ghrelin secretion promotor

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI754662B (en) * 2016-08-19 2022-02-11 日商明治股份有限公司 Composition for improving peripheral nerve damage caused by anticancer agent

Also Published As

Publication number Publication date
CN106535915B (en) 2020-09-29
JPWO2015199192A1 (en) 2017-06-08
TWI726846B (en) 2021-05-11
SG11201610051YA (en) 2017-01-27
JP6657084B2 (en) 2020-03-04
WO2015199192A1 (en) 2015-12-30
CN106535915A (en) 2017-03-22

Similar Documents

Publication Publication Date Title
TW201613631A (en) Ghrelin secretion promoter
EP4275760A3 (en) Egg protein formulations and methods of manufacture thereof
EP3217807A4 (en) Methods and compositions for egg white protein production
MX2016011641A (en) Method for preparing human plasma proteins.
IN2014MN00968A (en)
EP3009505A4 (en) Recombinant strain producing l-amino acids, constructing method therefor and method for producing l-amino acids.
MX2019013670A (en) Antibody and protein formulations.
MX2019003214A (en) Stable dual variable domain immunoglobulin protein formulations.
CR20170197A (en) PROTEINS OF VARIANTS OF SEQUENCES OF AMINO ACIDS OF CRY1DA1 ACTIVE FOR LEPIDOPTERS
MY170876A (en) Dairy product and process
EA201692025A1 (en) DELIVERY OF PROTEINS, BASED ON BACTERIA
PL3253453T3 (en) Method for the production of milk with high native vitamin d content
MX2020012356A (en) Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins.
EP2964775A4 (en) Yeast promoters for protein expression
EP4285930A3 (en) Protein formulations
MX2017000014A (en) METHOD FOR PRODUCING MEDIUM-CHAIN FATTY ACID USING ß-KETOACYL-ACP SYNTHASE.
AU2018201444B2 (en) High fat human milk products
EP3245296A4 (en) In vitro method for estimating in vivo protein digestibility
FI20146133A7 (en) A method for producing a spoonable acidified milk product
EP3562837A4 (en) Modified lysine decarboxylase enzymes
PH12018550097A1 (en) Infant formula comprising human milk peptides
MY184391A (en) Microorganism having improved intracellular energy level and method for producing l-amino acid using same
EP3604542A4 (en) Expression of phytase in aspergillus niger
PH12016501326A1 (en) (s)-3'-methyl-abscisic acid and esters thereof
EP3098313A4 (en) Method for producing rare fatty acid using novel enzyme, and novel rare fatty acid